TDOC Teladoc Health, Inc. Common Stock
Sobre Teladoc Health, Inc. Common Stock Visão geral da empresa da Wikipedia
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
Ler mais
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.
History
2002–2015
Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.
Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.
2015–2016
Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.
In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.
In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.
2017–2020
In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.
On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.
Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.
In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.
2021–2024
In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.
On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.
Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.
In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.
In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.
2025–present
In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.
In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.
The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.
Services and business model
Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.
Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.
By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.
Disaster aid
Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.
Lobbying and legislation
Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.
In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.
In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
TDOC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
TDOC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
TDOC Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 4 12,9%
- Compra 7 22,6%
- Manter 20 64,5%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
19 analistas · 2026-08-14Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.21 | $-0.25 | 0.04% |
| 31 de Março de 2026 | $-0.36 | $-0.32 | -0.04% |
| 31 de Dezembro de 2025 | $-0.14 | $-0.19 | 0.05% |
| 30 de Setembro de 2025 | $-0.28 | $-0.27 | -0.01% |
| 30 de Junho de 2025 | $-0.19 | $-0.27 | 0.08% |
| 31 de Março de 2025 | $-0.53 | $-0.34 | -0.19% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
| EVH | — | -0.8 | -26.6% | -28.5% | -81.5% | — |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
Balanço Patrimonial 28
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
Demonstração de Resultados 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
Balanço Patrimonial 25
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
Fluxo de Caixa 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
Avaliação (TTM) 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.50B | · | $2.53B | $2.54B | $2.56B | · | $2.59B | $2.60B | $2.59B | · | $2.55B | $2.49B | $2.40B | · | $2.29B | |
| Net Income TTM | $-185M | $-239M | · | $-208M | $-997M | $-1.05B | · | $-1.01B | $-1.04B | $-273M | · | $-265M | $-3.31B | $-9.92B | · | $-9.93B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.2 | -4.0 | · | -6.5 | -1.5 | -1.3 | · | -1.5 | -1.6 | -9.1 | · | -11.5 | -1.2 | -0.4 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.7 | 1.8 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| P / FCF | · | 125.2 | · | · | · | 105.8 | · | · | · | 329.0 | · | · | · | 393.4 | · | · | |
| Earnings Yield | -12.3% | -24.9% | · | -15.4% | -66.9% | -77.0% | · | -64.8% | -63.0% | -11.0% | · | -8.7% | -80.9% | -238.1% | · | -243.7% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Margem Operacional % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| Lucro líquido | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| EPS Diluído | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | — | — | — | 0.0 |
| Índice de liquidez corrente | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| Índice de Liquidez Seca | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $285M | $283M | $339M | $173M | $185M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 398 declarantes · $1.2B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 73 (+11 vs trimestre anterior) | 33 (-40 vs trimestre anterior) | 104 (-10 vs trimestre anterior) | 88 (+3 vs trimestre anterior) | +36.3M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $139.930.938 | 19.990.134 | 11,50% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.573.820 | 12.685.592 | 8,84% | Ações |
| Point72 Asset Management, L.P. | $69.874.581 | 8.239.927 | 5,74% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $68.457.700 | 8.072.842 | 5,63% | Ações |
| Voss Capital, LP | $68.235.838 | 8.046.679 | 5,61% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.458.671 | 7.955.032 | 5,55% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $59.415.442 | 7.006.538 | 4,88% | Ações |
| STATE STREET CORP | $42.080.999 | 4.962.382 | 3,46% | Ações |
| AMERICAN CENTURY COMPANIES INC | $41.505.394 | 4.894.504 | 3,41% | Ações |
| Allianz Asset Management GmbH | $39.572.734 | 4.666.596 | 3,25% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $33.651.520 | 3.967.415 | 2,77% | Ações |
| Monaco Asset Management SAM | $26.864.462 | 3.167.979 | 2,21% | Ações |
| JUPITER ASSET MANAGEMENT LTD | $26.370.375 | 3.109.714 | 2,17% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.976.377 | 3.063.252 | 2,14% | Ações |
| GOLDMAN SACHS GROUP INC | $25.430.579 | 2.998.889 | 2,09% | Ações |
| Quantinno Capital Management LP | $23.904.416 | 2.818.917 | 1,97% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17.299.632 | 2.040.051 | 1,42% | Ações |
| AMERIPRISE FINANCIAL INC | $16.946.398 | 1.998.396 | 1,39% | Ações |
| Pale Fire Capital SE | $16.737.502 | 1.973.762 | 1,38% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.435.088 | 1.938.100 | 1,35% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.710.032 | 1.380.900 | 0,96% | Opção de venda |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11.348.708 | 1.338.291 | 0,93% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $10.120.074 | 1.193.405 | 0,83% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $9.796.800 | 1.155.283 | 0,81% | Ações |
| Freestone Grove Partners LP | $7.338.160 | 865.349 | 0,60% | Ações |
| Man Group plc | $6.880.545 | 811.385 | 0,57% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $6.795.228 | 801.324 | 0,56% | Ações |
| CITADEL ADVISORS LLC | $6.795.024 | 801.300 | 0,56% | Opção de venda |
| Union Square Park Capital Management, LLC | $6.784.000 | 800.000 | 0,56% | Ações |
| CITADEL ADVISORS LLC | $6.532.093 | 770.294 | 0,54% | Ações |
| FMR LLC | $6.418.334 | 756.879 | 0,53% | Ações |
| TCW GROUP INC | $6.248.039 | 736.797 | 0,51% | Ações |
| Voss Capital, LP | $5.936.000 | 700.000 | 0,49% | Opção de compra |
| Empowered Funds, LLC | $5.764.619 | 679.790 | 0,47% | Ações |
| PEAK6 LLC | $5.227.920 | 616.500 | 0,43% | Opção de compra |
| CITADEL ADVISORS LLC | $5.114.288 | 603.100 | 0,42% | Opção de compra |
| Squarepoint Ops LLC | $5.089.696 | 600.200 | 0,42% | Opção de compra |
| JANE STREET GROUP, LLC | $5.088.848 | 600.100 | 0,42% | Opção de venda |
| FRANKLIN RESOURCES INC | $4.518.161 | 532.802 | 0,37% | Ações |
| TWO SIGMA ADVISERS, LP | $4.211.319 | 601.617 | 0,35% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.706 | 436.404 | 0,30% | Ações |
| WOLVERINE TRADING, LLC | $3.607.180 | 439.900 | 0,30% | Opção de compra |
| Parallax Volatility Advisers, L.P. | $3.392.000 | 400.000 | 0,28% | Opção de compra |
| TUDOR INVESTMENT CORP ET AL | $3.288.603 | 387.807 | 0,27% | Ações |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $3.248.866 | 383.121 | 0,27% | Ações |
| Swiss National Bank | $3.035.857 | 358.002 | 0,25% | Ações |
| BANK OF AMERICA CORP /DE/ | $2.894.928 | 341.383 | 0,24% | Ações |
| ALLIANCEBERNSTEIN L.P. | $2.781.435 | 510.355 | 0,23% | Ações |
| Squarepoint Ops LLC | $2.761.936 | 325.700 | 0,23% | Opção de venda |
| Trexquant Investment LP | $2.755.932 | 324.992 | 0,23% | Ações |
| D. E. Shaw & Co., Inc. | $2.544.000 | 300.000 | 0,21% | Opção de venda |
| ORACLE INVESTMENT MANAGEMENT INC | $2.480.366 | 354.338 | 0,20% | Ações |
| Soviero Asset Management, LP | $2.442.240 | 288.000 | 0,20% | Opção de compra |
| D. E. Shaw & Co., Inc. | $2.371.941 | 279.710 | 0,20% | Ações |
| BlackRock, Inc. | $2.312.106 | 272.654 | 0,19% | Ações |
| IEQ CAPITAL, LLC | $2.273.165 | 268.062 | 0,19% | Ações |
| JANE STREET GROUP, LLC | $2.155.616 | 254.200 | 0,18% | Opção de compra |
| WOLVERINE TRADING, LLC | $2.059.020 | 251.100 | 0,17% | Opção de venda |
| RHUMBLINE ADVISERS | $2.058.803 | 242.785 | 0,17% | Ações |
| Walleye Trading LLC | $2.017.188 | 237.876 | 0,17% | Ações |
| WINTON GROUP Ltd | $1.925.808 | 227.100 | 0,16% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.906.796 | 224.858 | 0,16% | Ações |
| Brevan Howard Capital Management LP | $1.880.084 | 221.708 | 0,15% | Ações |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1.704.675 | 243.525 | 0,14% | Ações |
| UBS Group AG | $1.696.000 | 200.000 | 0,14% | Opção de compra |
| NOMURA HOLDINGS INC | $1.696.000 | 200.000 | 0,14% | Opção de venda |
| Parker Investment Management, LLC | $1.586.515 | 187.089 | 0,13% | Ações |
| OPPENHEIMER & CO INC | $1.571.268 | 185.291 | 0,13% | Ações |
| ABS Direct Equity Fund LLC | $1.513.154 | 178.438 | 0,12% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.495.703 | 274.441 | 0,12% | Ações |
| Summit Trail Advisors, LLC | $1.488.766 | 175.562 | 0,12% | Ações |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $1.484.000 | 175.000 | 0,12% | Ações |
| SIMPLEX TRADING, LLC | $1.396.808 | 164.718 | 0,11% | Ações |
| BARCLAYS PLC | $1.347.861 | 158.946 | 0,11% | Ações |
| NATIXIS | $1.347.472 | 158.900 | 0,11% | Ações |
| WELLS FARGO & COMPANY/MN | $1.346.183 | 158.748 | 0,11% | Ações |
| JENNISON ASSOCIATES LLC | $1.333.793 | 157.287 | 0,11% | Ações |
| Rock Creek Group LLC | $1.329.944 | 156.833 | 0,11% | Ações |
| MACKENZIE FINANCIAL CORP | $1.297.381 | 152.993 | 0,11% | Ações |
| Walleye Trading LLC | $1.277.936 | 150.700 | 0,11% | Opção de venda |
| Counterpoint Mutual Funds LLC | $1.252.301 | 147.677 | 0,10% | Ações |
| MILLENNIUM MANAGEMENT LLC | $1.233.111 | 145.414 | 0,10% | Ações |
| Balyasny Asset Management L.P. | $1.226.208 | 144.600 | 0,10% | Opção de venda |
| TWO SIGMA INVESTMENTS, LP | $1.217.245 | 143.543 | 0,10% | Ações |
| ALGERT GLOBAL LLC | $1.211.792 | 142.900 | 0,10% | Ações |
| Engineers Gate Manager LP | $1.204.499 | 142.040 | 0,10% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.187.666 | 140.055 | 0,10% | Ações |
| Walleye Capital LLC | $1.082.896 | 127.700 | 0,09% | Opção de compra |
| Leonteq Securities AG | $1.064.384 | 125.517 | 0,09% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.045.813 | 123.327 | 0,09% | Ações |
| JANUS HENDERSON GROUP PLC | $1.038.988 | 190.640 | 0,09% | Ações |
| Walleye Capital LLC | $989.616 | 116.700 | 0,08% | Opção de venda |
| Crawford Fund Management, LLC | $987.072 | 116.400 | 0,08% | Opção de venda |
| OP Asset Management Ltd | $958.969 | 113.086 | 0,08% | Ações |
| Vanguard Global Advisers, LLC | $932.469 | 109.961 | 0,08% | Ações |
| CHIRON CAPITAL MANAGEMENT, LLC | $930.850 | 109.770 | 0,08% | Ações |
| Jefferies Financial Group Inc. | $907.657 | 107.035 | 0,07% | Ações |
| MetLife Investment Management, LLC | $901.746 | 106.338 | 0,07% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $891.845 | 96.104 | 0,07% | Ações |
| Y-Intercept (Hong Kong) Ltd | $876.815 | 103.398 | 0,07% | Ações |
Executivos da empresa 48 insiders · 23 diretores · 22 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 10 de Junho de 2026 M | 414.622 | 0 | 6 | $-938.572 |
| Jason N Gorevic | Chief Executive Officer | 4 de Março de 2022 M | 516.464 | 0 | 0 | $0 |
| Mala Murthy | Chief Financial Officer | 1 de Março de 2022 A | 17.357 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 13 de Dezembro de 2018 M | 10.000 | 0 | 0 | $0 |
| Kelly Bliss | President, U.S. Group Health | 6 de Julho de 2026 S | 84.878 | 0 | 4 | $-126.068 |
| Fernando M. Rodrigues | President of BetterHelp | 3 de Junho de 2026 S | 0 | 0 | 2 | $-114.131 |
| Carlos Nueno | President, International | 1 de Junho de 2026 M | 57.671 | 0 | 1 | $-47.257 |
| Peter A Mcclennen | President | 15 de Julho de 2019 M | 0 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 29 de Julho de 2021 M | 11.031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 1 de Julho de 2026 M | 12.267 | 0 | 2 | $-8.108 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 1 de Junho de 2026 M | 110.261 | 0 | 3 | $-241.831 |
| Daniel Trencher | SVP Corporate Strategy | 4 de Março de 2022 M | 29.408 | 0 | 0 | $0 |
| Stephany Verstraete | Chief Marketing Officer | 4 de Março de 2022 M | 31.828 | 0 | 0 | $0 |
| Andrew Turitz | SVP - Business Development | 4 de Março de 2022 M | 14.794 | 0 | 0 | $0 |
| Claus Torp Jensen | Chief Innovation Officer | 1 de Março de 2022 A | — | 0 | 0 | $0 |
| Arnnon Geshuri | Chief Human Resources Officer | 1 de Março de 2022 A | 83.168 | 0 | 0 | $0 |
| Richard J Napolitano | Chief Accounting Officer | 1 de Março de 2022 A | 1.195 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 1 de Outubro de 2020 M | 8.766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 1 de Setembro de 2020 M | 3.232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 1 de Julho de 2020 A | — | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 16 de Abril de 2020 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 25 de Maio de 2017 A | 61.459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 13 de Março de 2017 A | — | 0 | 0 | $0 |
| Mark V Anquillare | Conselheiro | 3 de Agosto de 2026 A | — | 0 | 0 | $0 |
| David B Snow JR | Conselheiro | 21 de Maio de 2026 A | 113.032 | 0 | 0 | $0 |
| David L Shedlarz | Conselheiro | 21 de Maio de 2026 A | 61.266 | 0 | 0 | $0 |
| Susan R Salka | Conselheiro | 30 de Março de 2026 A | — | 0 | 0 | $0 |
| Catherine Jacobson | Conselheiro | 18 de Fevereiro de 2022 M | 1.468 | 0 | 0 | $0 |
| William H. Frist | Conselheiro | 15 de Setembro de 2021 M | 12.918 | 0 | 0 | $0 |
| Karen L Daniel | Conselheiro | 25 de Agosto de 2021 M | 41.915 | 0 | 0 | $0 |
| Christopher Bischoff | Conselheiro | 25 de Maio de 2021 M | 5.121 | 0 | 0 | $0 |
| Mark Douglas Smith | Conselheiro | 17 de Maio de 2021 A | 3.536 | 0 | 0 | $0 |
| Kenneth H Paulus | Conselheiro | 17 de Maio de 2021 A | 0 | 0 | 0 | $0 |
| Thomas Mckinley | Conselheiro | 17 de Maio de 2021 A | 5.879 | 0 | 0 | $0 |
| Hemant Taneja | Conselheiro | 19 de Abril de 2021 S | 118.760 | 0 | 0 | $0 |
| Glen Tullman | Conselheiro | 1 de Abril de 2021 M | 275.793 | 0 | 0 | $0 |
| Helen Darling | Conselheiro | 11 de Junho de 2020 M | 918 | 0 | 0 | $0 |
| Arneek Multani | Conselheiro | 30 de Maio de 2019 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | Conselheiro | 30 de Maio de 2019 A | 1.965 | 0 | 0 | $0 |
| Tom Mawhinney | Conselheiro | 25 de Maio de 2018 M | 46.203 | 0 | 0 | $0 |
| Martin R Felsenthal | Conselheiro | 8 de Agosto de 2016 A | 10.860 | 0 | 0 | $0 |
| Dana G Mead Jr. | Conselheiro | 8 de Agosto de 2016 A | 202 | 0 | 0 | $0 |
| James K Outland | Conselheiro | 13 de Julho de 2015 M | 49.986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | Detentor de 10% | 26 de Abril de 2017 J | 2.480.468 | 0 | 0 | $0 |
| CHP III LP | Detentor de 10% | 26 de Abril de 2017 J | 2.480.468 | 0 | 0 | $0 |
| Sandra L Fenwick | — | 21 de Maio de 2026 A | 10.762 | 0 | 0 | $0 |
| Yulun Wang | — | 25 de Janeiro de 2021 S | 219.507 | 0 | 0 | $0 |
| Michael Goldstein | — | 11 de Junho de 2020 M | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 declarações | 15 de Abril de 2021 | — | Declaração inicial | — | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 declarações | 16 de Março de 2021 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 55 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| HEAL · Global X Funds | 1,18% | 38.782 NS | 31 de Maio de 2026 | N-PORT |
| SVAL · iShares Trust | 0,42% | 129.925 SH | 8 de Agosto de 2026 | Diário |
| JSML · Janus Detroit Street Trust | 0,34% | 178.607 NS | 30 de Abril de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 261.035 NS | 31 de Maio de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,18% | 66.764 NS | 31 de Maio de 2026 | N-PORT |
| IHF · iShares Trust | 0,18% | 332.174 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,10% | 159.976 SH | 8 de Agosto de 2026 | Diário |
| SMLF · iShares Trust | 0,09% | 592.154 SH | 8 de Agosto de 2026 | Diário |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 978.669 NS | 31 de Maio de 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2.910.344 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,08% | 1.690.654 SH | 8 de Agosto de 2026 | Diário |
| GINN · Goldman Sachs ETF Trust | 0,08% | 21.242 NS | 31 de Maio de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,07% | 920.742 NS | 30 de Abril de 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,07% | 155.542 NS | 30 de Abril de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 252.145 NS | 31 de Maio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 67.673 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.047.849 SH | 8 de Agosto de 2026 | Diário |
| VFMF · VANGUARD WELLINGTON FUND | 0,04% | 29.737 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,04% | 4.666.989 SH | 8 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | 0,04% | 38.629 SH | 8 de Agosto de 2026 | Diário |
| PNQI · Invesco Exchange-Traded Fund Trust | 0,04% | 26.986 SH | 8 de Agosto de 2026 | Diário |
| ITWO · ProShares Trust | 0,03% | 8.377 NS | 31 de Maio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 77.120 NS | 30 de Abril de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2.631.374 SH | 8 de Agosto de 2026 | Diário |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 858.463 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 584.184 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.084.219 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,02% | 4.153.113 SH | 8 de Agosto de 2026 | Diário |
| UWM · ProShares Trust | 0,02% | 6.552 NS | 31 de Maio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 535.056 SH | 8 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | 0,02% | 7.717 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 81.058 NS | 30 de Abril de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 10.585 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 6.629 NS | 31 de Maio de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 285.019 NS | 30 de Abril de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 170.044 SH | 8 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 10.387 SH | 8 de Agosto de 2026 | Diário |
| TILT · FlexShares Trust | 0,01% | 34.034 NS | 30 de Abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 6.863 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 166 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 422.235 NS | 30 de Abril de 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 9.970 NS | 31 de Maio de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,01% | 1.783 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 22.871 NS | 30 de Abril de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 11.743 NS | 30 de Abril de 2026 | N-PORT |
| DSI · iShares Trust | 0,00% | 25.216 SH | 8 de Agosto de 2026 | Diário |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 42.456 NS | 31 de Maio de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 105.579 NS | 31 de Maio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 232.888 SH | 8 de Agosto de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 45.271 SH | 8 de Agosto de 2026 | Diário |